Transient Receptor Potential Cation Channel, Subfamily C, Member 2 (TRPC2) (AA 180-188) Peptide
TRPC2
(1 reference)-
- 抗原 See all TRPC2 products
- TRPC2 (Transient Receptor Potential Cation Channel, Subfamily C, Member 2 (TRPC2))
- 蛋白结构域
- AA 180-188
- 纯化方法
- Rabbit Anti-cdc25C (Ab-216) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
- 限制
- 仅限研究用
-
- 储存条件
- -20 °C
-
-
: "Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-?+IL-17+ polyfunctional T cells that mediate rejection of murine tumors." in: Cancer research, Vol. 72, Issue 3, pp. 581-91, (2012) (PubMed).
-
: "Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-?+IL-17+ polyfunctional T cells that mediate rejection of murine tumors." in: Cancer research, Vol. 72, Issue 3, pp. 581-91, (2012) (PubMed).
-
- 抗原
- TRPC2 (Transient Receptor Potential Cation Channel, Subfamily C, Member 2 (TRPC2))
- 别名
- 3010009O07Rik Peptide, AI115608 Peptide, TRPC2a Peptide, TRPC2b Peptide, Trrp2 Peptide, mTrp2 Peptide, smTRPC2 Peptide, trp2 Peptide, transient receptor potential cation channel, subfamily C, member 2 Peptide, transient receptor potential channel 2 Peptide, transient receptor potential cation channel, subfamily C, member 2b Peptide, Trpc2 Peptide, TRPC2 Peptide, trpc2b Peptide
- 背景
- This peptide is a TRP-tyrosinase-related protein. Its immunization results in effective induction of antitumor immunity. Key Diseases for which peptide SVYDFFVWL is Melanoma, Neoplasms(cancer),Glioma. Drugs related to peptide SVYDFFVWL include mRNA, Liposomes, DNA, Atigens, Epitopes.
-
You are here:
